Dose escalation for patients with locally advanced nasopharyngeal carcinoma treated with radiotherapy alone

American Journal of Clinical Oncology: Cancer Clinical Trials

Volumn 30, Issue 4, 2007, Pages 401-405

  Yeh, Shyh An ^a   Huang, Yu Jie ^b  

^a E DA HOSPITAL   (Taiwan)

^b CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CANCER CONTROL; CANCER GROWTH; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER STAGING; CANCER THERAPY; DISEASE CLASSIFICATION; FEMALE; HEARING IMPAIRMENT; HISTOLOGY; HUMAN; INCIDENCE; IRRADIATION; MAJOR CLINICAL STUDY; MALE; METASTASIS; NASOPHARYNX CARCINOMA; PROGNOSIS; PROSPECTIVE STUDY; RADIATION DOSE; RADIATION NECROSIS; STATISTICAL SIGNIFICANCE; TAIWAN; XEROSTOMIA;

ADULT; AGED; CARCINOMA, SQUAMOUS CELL; DOSE-RESPONSE RELATIONSHIP, RADIATION; FEMALE; HUMANS; MALE; MIDDLE AGED; NASOPHARYNGEAL NEOPLASMS; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; PROSPECTIVE STUDIES; SURVIVAL RATE; TAIWAN;

EID: 34548450740     PISSN: 02773732     EISSN: 1537453X     Source Type: Journal    
DOI: 10.1097/COC.0b013e31803377b3     Document Type: Article

References (30)

1. Perez CA, Devineni VR, Marcial-Vega V, et al. Carcinoma of the nasopharynx: factors affecting prognosis. Int J Radiat Oncol Biol Phys. 1992;23:271-280.
2. Erkal HS, Serin M, Cakmak A. Nasopharyngeal carcinomas: analysis of patient, tumor and treatment characteristics determining outcome. Radiother Oncol. 2001;61:247-256.
3. Tang SG, Lin FJ, Chen MS, et al. Prognostic factors of nasopharyngeal carcinoma: a multivariate analysis. Int J Radiat Oncol Biol Phys. 1990;19:1143-1149.
4. Levendag PC, Schmitz PI, Jansen PP, et al. Fractionated high-dose-rate brachytherapy in primary carcinoma of the nasopharynx. J Clin Oncol. 1998;16:2213-2220.
5. Munro AJ. An overview of randomised controlled trials of adjuvant chemotherapy in head and neck cancer. Br J Cancer. 1995;71:83-91.
6. Jian JJ, Cheng SH, Prosnitz LR, et al. T classification and clivus margin as risk factors for determining locoregional control by radiotherapy of nasopharyngeal carcinoma. Cancer. 1998;82:261-267.
7. Teo PM, Leung SF, Fowler J, et al. Improved local control for early T-stage nasopharyngeal carcinoma: a tale of two hospitals. Radiother Oncol. 2000;57:155-166.
8. Vikram B, Mishra UB, Strong EW, et al. Patterns of failure in carcinoma of the nasopharynx: I. Failure at the primary site. Int J Radiat Oncol Biol Phys. 1985;11:1455-1459.
9. Beahrs OH, Henson DE, Hutter RVP, et al, eds. American Joint Committee on Cancer: Manual for Staging of Cancer, ed 4. Philadelphia: Lippincott, 1992.
10. Greene FL, Page DL, Fleming ID, et al, eds. American Joint Committee on Cancer: Cancer Staging Manual, ed 6. New York: Springer, 2002.
11. World Health Organization. International histological classification of tumors: histological typing of upper respiratory tract tumors. World Health Organization. 1978;19:32-33.
12. Cox JD, Stetz J, Pajak TF. Toxicity Criteria of the Radiation Therapy Oncology Group (RTOG) and the European Organization for Research and Treatment of Cancer (EORTC). Int J Radiat Oncol Biol Phys. 1995;31:1341-1346.
13. Pavy JJ, Denekamp J, Letschert J, et al. EORTC Late Effects Working Group. Late effects toxicity scoring: the SOMA scale. Int J Radiat Oncol Biol Phys. 1995;31:1043-1091.
14. Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc. 1958;53:457-481.
15. Peto R, Pike MC, Armitage P, et al. Design and analysis of randomized clinical trials requiring prolonged observation of each patient: II. Analysis and examples. Br J Cancer. 1977;35:1-39.
16. Cox DR. Regression models and life tables. J Royal Stat Soc. 1972;34:187-220.
17. Sham JS, Choy D. Prognostic factors of nasopharyngeal carcinoma: a review of 759 patients. Br J Radiol. 1990;63:51-58.
18. Geara FB, Sanguineti G, Tucker SL, et al. Carcinoma of the nasopharynx treated by radiotherapy alone: determinants of distant metastasis and survival. Radiother Oncol. 1997;43:53-61.
19. Zhang EP, Lian PG, Cai KL, et al. Radiation therapy of nasopharyngeal carcinoma: prognostic factors based on a 10-year follow-up of 1302 patients. Int J Radiat Oncol Biol Phys. 1989;16:301-305.
20. Chang JT, See LC, Tang SG, et al. The role of brachytherapy in early-stage nasopharyngeal carcinoma. Int J Radiat Oncol Biol Phys. 1996;36:1019-1024.
21. Ozyar E, Yildz F, Akyol FH, et al. Adjuvant high-dose-rate brachytherapy after external beam radiotherapy in nasopharyngeal carcinoma. Int J Radiat Oncol Biol Phys. 2002;52:101-108.
22. Teo PM, Leung SF, Chan AT, et al. Final report of a randomized trial on altered-fractionated radiotherapy in nasopharyngeal carcinoma prematurely terminated by significant increase in neurologic complications. Int J Radiat Oncol Biol Phys. 2000;48:1311-1322.
23. Le QT, Tate D, Koong A, et al. Improved local control with stereotactic radiosurgical boost in patients with nasopharyngeal carcinoma. Int J Radiat Oncol Biol Phys. 2003;56:1046-1054.
24. Leibel SA, Kutcher GJ, Harrison LB, et al. Improved dose distributions for 3D conformal boost treatments in carcinoma of the nasopharynx. Int J Radiat Oncol Biol Phys. 1991;20:823-833.
25. Wolden SL, Zelefsky MJ, Hunt MA, et al. Failure of a 3D conformal boost to improve radiotherapy for nasopharyngeal carcinoma. Int J Radiat Oncol Biol Phys. 2001;49:1229-1234.
26. Khoo VS, Dearnaley DP, Finnigan DJ, et al. Magnetic resonance imaging (MRI): considerations and applications in radiotherapy treatment planning. Radiother Oncol. 1997;42:1-15.
27. Khoo VS, Adams EJ, Saran F, et al. A comparison of clinical target volumes determined by CT and MRI for the radiotherapy planning of base of skull meningiomas. Int J Radiat Oncol Biol Phys. 2000;46:1309-1317.
28. Aoyama H, Shirato H, Nishioka T, et al. Magnetic resonance imaging system for three-dimensional conformal radiotherapy and its impact on gross tumor volume delineation of central nervous system tumors. Int J Radiat Oncol Biol Phys. 2001;50:821-827.
29. Emami B, Sethi A, Petruzzelli GJ. Influence of MRI on target volume delineation and IMRT planning in nasopharyngeal carcinoma. Int J Radiat Oncol Biol Phys. 2003;57:481-488.
30. Chung NN, Ting LL, Hsu WC, et al. Impact of magnetic resonance imaging versus CT on nasopharyngeal carcinoma: primary tumor target delineation for radiotherapy. Head Neck. 2004;26:241-246.